These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6296567)

  • 1. Receptor-related interactions of opiates with PGE-induced adenylate cyclase in brain.
    Barchfeld CC; Maassen ZF; Medzihradsky F
    Life Sci; 1982 Oct 18-25; 31(16-17):1661-5. PubMed ID: 6296567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine 3':5'-cyclic monophosphate (cAMP) is not the mediator of kappa opiate effect on human placental lactogen release.
    Petit A; Gallo-Payet N; Lehoux JG; Bellabarba D; Bélisle S
    Life Sci; 1991; 49(6):465-72. PubMed ID: 1650874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
    Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes.
    Cooper DM; Londos C; Gill DL; Rodbell M
    J Neurochem; 1982 Apr; 38(4):1164-7. PubMed ID: 6278084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of opiates and prostaglandins E with regard to cyclic AMP in striatal tissue of rats in vitro.
    Havemann U; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Mar; 302(1):103-6. PubMed ID: 206843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum.
    Gentleman S; Parenti M; Neff NH; Pert CB
    Cell Mol Neurobiol; 1983 Mar; 3(1):17-26. PubMed ID: 6309392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord.
    Attali B; Saya D; Vogel Z
    J Neurochem; 1989 Feb; 52(2):360-9. PubMed ID: 2536070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate tolerance and dependence is associated with a decreased activity of GTPase in rat striatal membranes.
    Parenti M; Gazzotti G; Tirone F; Groppetti A
    Life Sci; 1983; 33 Suppl 1():345-8. PubMed ID: 6141494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of opiates on human colonic adenylate cyclase activity.
    Rachmilewitz D; Karmeli F; Chorev M; Selinger Z
    Eur J Pharmacol; 1983 Sep; 93(3-4):169-73. PubMed ID: 6580173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the desensitization by morphine of the opiate-dependent adenylate cyclase system in the rat striatum on the activity of the inhibitory regulatory G protein.
    Tirone F; Viganó A; Groppetti A; Parenti M
    Biochem Pharmacol; 1988 Mar; 37(6):1039-44. PubMed ID: 2833270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor-sensitive adenylate cyclase is inhibited by activation of mu-opioid receptors in rat striatal neurons.
    Van Vliet BJ; Ruuls SR; Drukarch B; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1991 Mar; 195(2):295-300. PubMed ID: 1651867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinities of opiate agonists and antagonists for the enkephalin receptors of rat brain.
    Wong DT; Horng JS
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):749-52. PubMed ID: 193169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of morphine of prostaglandin E2 (PGE2)-sensitive adenylate cyclase in corpus striatum of rats and its cellular localization by using kainic acid.
    Havemann U; Kuschinsky K
    Brain Res; 1978 Jul; 150(2):441-5. PubMed ID: 209852
    [No Abstract]   [Full Text] [Related]  

  • 19. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiates modulation of cAMP levels and PGE2 binding in mammalian sympathetic ganglia.
    Borasio PG; Biondi C; Capuzzo A; Ferretti ME
    Neurosci Lett; 1986 May; 66(1):7-12. PubMed ID: 2872633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.